Chirality-dependent supramolecular synthons based on the 1,3-oxazolidin-2-one framework: chiral drugs mephenoxalone, metaxalone and 114 other examples

被引:7
作者
Bredikhin, Alexander A. [1 ]
Bredikhina, Zemfira A. [1 ]
Gubaidullin, Aidar T. [1 ]
机构
[1] RAS, FRC Kazan Sci Ctr, Arbuzov Inst Organ & Phys Chem, Arbuzov St 8, Kazan 420088, Russia
关键词
CRYSTAL-STRUCTURE; SPONTANEOUS RESOLUTION; GUAIFENESIN; METHOCARBAMOL; PATTERNS; FALSE;
D O I
10.1039/d0ce00116c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In four of the five crystalline modifications of the muscle relaxants mephenoxalone 3 and metaxalone 2, chain supramolecular motifs of three different types are realized. The centrosymmetric cyclic dimer, which is considered typical of amides, was found only once. To clarify the nature of the emerging supramolecular synthons, the set of 119 crystal structures of 1,3-oxazolidin-2-one 1 derivatives, to which drugs 2 and 3 belong, were selected from the Cambridge Structural Database. Analysis of the sample showed that oxazolidinone fragments predominantly form closed ring synthons in racemic crystals, whereas linear chains are typical for enantiopure ones. Thus, in the case of chiral objects, the transition from racemic to enantiopure crystal serves as a powerful tool for designing crystals with a given organization of supramolecular synthon. Two earlier unidentified kryptoracemates (false conglomerates), QEFJAP and QEFJUJ, were found among the analyzed set. Apparently, these are the first representatives of oxazolidinones exhibiting this rare property.
引用
收藏
页码:7252 / 7261
页数:10
相关论文
共 33 条
[1]   Conformational Polymorphs of a Muscle Relaxant, Metaxalone [J].
Aitipamula, Srinivasulu ;
Chow, Pui Shan ;
Tan, Reginald B. H. .
CRYSTAL GROWTH & DESIGN, 2011, 11 (09) :4101-4109
[2]   Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[3]  
[Anonymous], 2006, APEX2 VERSION 2 1 SA
[4]   PATTERNS IN HYDROGEN BONDING - FUNCTIONALITY AND GRAPH SET ANALYSIS IN CRYSTALS [J].
BERNSTEIN, J ;
DAVIS, RE ;
SHIMONI, L ;
CHANG, NL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1995, 34 (15) :1555-1573
[5]   Multiple Molecules in the Asymmetric Unit (Z′ > 1) and the Formation of False Conglomerate Crystal Structures [J].
Bishop, Roger ;
Scudder, Marcia L. .
CRYSTAL GROWTH & DESIGN, 2009, 9 (06) :2890-2894
[6]   Chiral drugs related to guaifenesin: synthesis and phase properties of methocarbamol and mephenoxalone [J].
Bredikhin, Alexander A. ;
Bredikhina, Zemfira A. ;
Zakharychev, Dmitry V. ;
Pashagin, Alexander V. .
TETRAHEDRON-ASYMMETRY, 2007, 18 (10) :1239-1244
[7]   Solid Phase Behavior, Polymorphism, and Crystal Structure Features of Chiral Drug Metaxalone [J].
Bredikhin, Alexander A. ;
Zakharychev, Dmitry V. ;
Gubaidullin, Aidar T. ;
Bredikhina, Zemfira A. .
CRYSTAL GROWTH & DESIGN, 2018, 18 (11) :6627-6639
[8]   Stereoselective Crystallization as a Basis for Single-Enantiomer Drug Production [J].
Bredikhin, Alexander A. ;
Bredikhina, Zemfira A. .
CHEMICAL ENGINEERING & TECHNOLOGY, 2017, 40 (07) :1211-1220
[9]   Absolute configuration and crystal packing for three chiral drugs prone to spontaneous resolution: Guaifenesin, methocarbamol and mephenesin [J].
Bredikhin, Alexander A. ;
Gubaidullin, Aidar T. ;
Bredikhina, Zemfira A. ;
Krivolapov, Dmitry B. ;
Pashagin, Alexander V. ;
Litvinov, Igor A. .
JOURNAL OF MOLECULAR STRUCTURE, 2009, 920 (1-3) :377-382
[10]   Solid state properties and effective resolution procedure for guaifenesin, 3-(2-methoxyphenoxy)-1,2-propanediol [J].
Bredikhina, Zemfira A. ;
Novikova, Victorina G. ;
Zakharychev, Dmitry V. ;
Bredikhin, Alexander A. .
TETRAHEDRON-ASYMMETRY, 2006, 17 (21) :3015-3020